Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Prospero Biosciences
AddedFeb 17, 2024
UpdatedJun 18, 2026
Prospero Biosciences

Prospero Biosciences

Prospero Biosciences revolutionizes protein analysis with patented ultra-high mass detection systems, advancing scientific and clinical research.

HQ
Sun Prairie, WI, US
Founded
2012
Overview
Compare
Fundraising
Employees

Prospero Biosciences revolutionizes protein analysis with patented ultra-high mass detection systems, advancing scientific and clinical research. Their core products include retrofitting solutions for MALDI-TOF mass spectrometric instruments, with future plans to expand to ESI and Q-TOF instruments. The company focuses on enhancing the dynamic range and resolution of protein mass analysis, catering to scientists and clinicians.

Prospero Biosciences has achieved significant advancements in extending the dynamic range limits of protein mass analysis, providing unprecedented resolution. Their innovative technology has garnered attention in the scientific community, positioning them as a leader in the field. The company's impact is evident in the enhanced capabilities it offers to researchers and clinicians, driving forward the frontiers of protein analysis.

Prospero Biosciences - Similar Companies

Protea Biosciences logo

Protea Biosciences

proteabio.com

NEO Proteomics logo

NEO Proteomics

neoproteomics.net

Revolution Biosciences logo

Revolution Biosciences

Protein Dynamic Solutions logo

Protein Dynamic Solutions

pdsbio.com

Prospect Bio logo

Prospect Bio

Probius logo

Probius

probius.bio

Perfinity Biosciences logo

Perfinity Biosciences

perfinity.com

Impact Proteomics logo

Impact Proteomics

ProteoWise logo

ProteoWise

proteowise.com

Seer logo

Seer

seer.bio

Proterixbio logo

Proterixbio

Trace Matters logo

Trace Matters

tracematters.com

Adeptrix logo

Adeptrix

adeptrix.com

Solus Biosystems logo

Solus Biosystems

Range Biotechnologies logo

Range Biotechnologies

range.bio

Prospero Biosciences - Quick Facts

Who are Prospero Biosciences' competitors?

Companies similar to Prospero Biosciences include Protea Biosciences, NEO Proteomics, Revolution Biosciences and Protein Dynamic Solutions.

When was Prospero Biosciences founded?

Prospero Biosciences was founded in 2012.

Where is Prospero Biosciences' headquarters located?

Prospero Biosciences' headquarters is located in Sun Prairie, WI, US.

When was Prospero Biosciences' last funding round?

Prospero Biosciences' most recent funding round was for $15k (USD) in November 2013.

How much has Prospero Biosciences raised to-date?

As of Nov 11, 2013, Prospero Biosciences has raised a total of $15k (USD).

How many employees does Prospero Biosciences have?

Prospero Biosciences has 7 employees as of Feb 4, 2024.

Prospero Biosciences - Classification

Industry
  • Hardware
Ownership
  • Private
  • Venture Capital
Technology
  • Analytics
Geographic Exposure
  • Global
Customer
  • Enterprise
Main Product
  • Mass Spectrometry
Tags
  • Biotech
  • Consulting
  • Research
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software